Stay Updated with the Latest UTI Mutual Fund - UTI-Nifty Next 50 Exchange Traded Fund UTINEXT50.BO News in Real Time
Find UTINEXT50.BO news now at Meyka AI. Stay informed with the latest UTI Mutual Fund - UTI-Nifty Next 50 Exchange Traded Fund stocks updates, including price news, market analysis, and expert insights.
Sui USD Surges 15.9% to $0.8508 as RSI Hits 66.9 on Strong Momentum
Sui USD jumped 15.9% to $0.8508 in 24 hours with volume 2.3x average. RSI at 66.9 and ADX at 29.95 signal strong upward momentum.
Bitcoin Cash Surges 23% to $274.84 as Japan Licensing Fuels Institutional Demand
Bitcoin Cash jumped 23.3% to $274.84 on August 23, 2026, after Japan approved its first new crypto trading license in four years, enabling regulated access for professional investors.
Social Security Benefits Face 22% Cut by 2032 Without Congressional Action
Social Security trust fund projected to deplete by 2032, triggering a 22% automatic benefit cut unless Congress passes reform. Three main proposals being debated.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Bitcoin Jumps 6.4% to $77,699 as Volatility-Adjusted Rally Signals Regime Shift
Bitcoin surges 6.4% to $77,699 in a volatility-adjusted move analysts compare to the fifth-largest since 2018, signaling a potential bull market inflection.
Lido Staked ETH USD Rallies 5.9% to $2,462 as Momentum Indicators Flash Overbought
STETHUSD jumped 5.9% to $2,462.17 in 24 hours with RSI at 83.88 and price above Bollinger upper band, signaling extreme overbought conditions.
Ethereum Surges 5.9% to $2,464.69 as RSI Hits Extreme Overbought 84.7
Ethereum USD jumped 5.9% to $2,464.69 in 24 hours with RSI at 84.7, signaling extreme overbought conditions and a potential pullback.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.